The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer

Benjamin J. Davies, Marc C. Smaldone, Natalia Sadetsky, Marc Dall'Era, Peter R. Carroll

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: We examined the impact of obesity on disease specific and overall survival in patients with prostate cancer. Materials and Methods: We identified 7,274 men from the Cancer of the Prostate Strategic Urological Research Endeavor database with clinically localized prostate cancer, known body mass index and clinicopathological disease characteristics. Patients were classified by body mass index as normal (less than 25 kg/m2), overweight (25 to 29.9 kg/m2), obese (30 to 34.9 kg/m2) and severely obese (35 kg/m2 or greater). Associations between body mass index and need for secondary treatment, disease specific survival and overall survival were analyzed using univariate and multivariate models. Results: Patients were classified by body mass index category as normal (28.8%), overweight (50%), obese (16.4%) and very obese (4.8%). Mean followup was 51.3 ± 38.5 months. During followup there were 1,044 deaths with 220 (21.1%) from prostate cancer. Stratified by body mass index category the groups differed with regard to the need for secondary treatment (p = 0.05) and overall mortality (p <0.01) but there were no significant differences with regard to disease specific survival (p = 0.09). On multivariate analysis age 65 to 74 years (HR 2.4, p = 0.002), age older than 75 years (HR 3.2, p = 0.0001), high risk disease (HR 1.6, p <0.0001), conservative treatment (HR 1.2, p <0.0001) and presence of diabetes (HR 1.6, p <0.0001) were associated with decreased overall survival. Only conservative treatment (HR 1.4, p <0.0001), high risk disease (HR 8.4, p <0.0001) and intermediate risk disease (HR 2.5, p = 0.004) were associated with decreased disease specific survival. Conclusions: In a prospective, community based cohort we were unable to establish a relationship between body mass index and prostate cancer disease specific survival or overall survival.

Original languageEnglish (US)
Pages (from-to)112-117
Number of pages6
JournalJournal of Urology
Volume182
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Prostatic Neoplasms
Obesity
Survival
Body Mass Index
Neoplasms
Multivariate Analysis
Databases
Mortality
Therapeutics
Research

Keywords

  • body mass index
  • mortality
  • obesity
  • prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer. / Davies, Benjamin J.; Smaldone, Marc C.; Sadetsky, Natalia; Dall'Era, Marc; Carroll, Peter R.

In: Journal of Urology, Vol. 182, No. 1, 07.2009, p. 112-117.

Research output: Contribution to journalArticle

Davies, Benjamin J. ; Smaldone, Marc C. ; Sadetsky, Natalia ; Dall'Era, Marc ; Carroll, Peter R. / The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer. In: Journal of Urology. 2009 ; Vol. 182, No. 1. pp. 112-117.
@article{a6ce3942bf7746eab16f162fe36df157,
title = "The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer",
abstract = "Purpose: We examined the impact of obesity on disease specific and overall survival in patients with prostate cancer. Materials and Methods: We identified 7,274 men from the Cancer of the Prostate Strategic Urological Research Endeavor database with clinically localized prostate cancer, known body mass index and clinicopathological disease characteristics. Patients were classified by body mass index as normal (less than 25 kg/m2), overweight (25 to 29.9 kg/m2), obese (30 to 34.9 kg/m2) and severely obese (35 kg/m2 or greater). Associations between body mass index and need for secondary treatment, disease specific survival and overall survival were analyzed using univariate and multivariate models. Results: Patients were classified by body mass index category as normal (28.8{\%}), overweight (50{\%}), obese (16.4{\%}) and very obese (4.8{\%}). Mean followup was 51.3 ± 38.5 months. During followup there were 1,044 deaths with 220 (21.1{\%}) from prostate cancer. Stratified by body mass index category the groups differed with regard to the need for secondary treatment (p = 0.05) and overall mortality (p <0.01) but there were no significant differences with regard to disease specific survival (p = 0.09). On multivariate analysis age 65 to 74 years (HR 2.4, p = 0.002), age older than 75 years (HR 3.2, p = 0.0001), high risk disease (HR 1.6, p <0.0001), conservative treatment (HR 1.2, p <0.0001) and presence of diabetes (HR 1.6, p <0.0001) were associated with decreased overall survival. Only conservative treatment (HR 1.4, p <0.0001), high risk disease (HR 8.4, p <0.0001) and intermediate risk disease (HR 2.5, p = 0.004) were associated with decreased disease specific survival. Conclusions: In a prospective, community based cohort we were unable to establish a relationship between body mass index and prostate cancer disease specific survival or overall survival.",
keywords = "body mass index, mortality, obesity, prostatic neoplasms",
author = "Davies, {Benjamin J.} and Smaldone, {Marc C.} and Natalia Sadetsky and Marc Dall'Era and Carroll, {Peter R.}",
year = "2009",
month = "7",
doi = "10.1016/j.juro.2009.02.118",
language = "English (US)",
volume = "182",
pages = "112--117",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer

AU - Davies, Benjamin J.

AU - Smaldone, Marc C.

AU - Sadetsky, Natalia

AU - Dall'Era, Marc

AU - Carroll, Peter R.

PY - 2009/7

Y1 - 2009/7

N2 - Purpose: We examined the impact of obesity on disease specific and overall survival in patients with prostate cancer. Materials and Methods: We identified 7,274 men from the Cancer of the Prostate Strategic Urological Research Endeavor database with clinically localized prostate cancer, known body mass index and clinicopathological disease characteristics. Patients were classified by body mass index as normal (less than 25 kg/m2), overweight (25 to 29.9 kg/m2), obese (30 to 34.9 kg/m2) and severely obese (35 kg/m2 or greater). Associations between body mass index and need for secondary treatment, disease specific survival and overall survival were analyzed using univariate and multivariate models. Results: Patients were classified by body mass index category as normal (28.8%), overweight (50%), obese (16.4%) and very obese (4.8%). Mean followup was 51.3 ± 38.5 months. During followup there were 1,044 deaths with 220 (21.1%) from prostate cancer. Stratified by body mass index category the groups differed with regard to the need for secondary treatment (p = 0.05) and overall mortality (p <0.01) but there were no significant differences with regard to disease specific survival (p = 0.09). On multivariate analysis age 65 to 74 years (HR 2.4, p = 0.002), age older than 75 years (HR 3.2, p = 0.0001), high risk disease (HR 1.6, p <0.0001), conservative treatment (HR 1.2, p <0.0001) and presence of diabetes (HR 1.6, p <0.0001) were associated with decreased overall survival. Only conservative treatment (HR 1.4, p <0.0001), high risk disease (HR 8.4, p <0.0001) and intermediate risk disease (HR 2.5, p = 0.004) were associated with decreased disease specific survival. Conclusions: In a prospective, community based cohort we were unable to establish a relationship between body mass index and prostate cancer disease specific survival or overall survival.

AB - Purpose: We examined the impact of obesity on disease specific and overall survival in patients with prostate cancer. Materials and Methods: We identified 7,274 men from the Cancer of the Prostate Strategic Urological Research Endeavor database with clinically localized prostate cancer, known body mass index and clinicopathological disease characteristics. Patients were classified by body mass index as normal (less than 25 kg/m2), overweight (25 to 29.9 kg/m2), obese (30 to 34.9 kg/m2) and severely obese (35 kg/m2 or greater). Associations between body mass index and need for secondary treatment, disease specific survival and overall survival were analyzed using univariate and multivariate models. Results: Patients were classified by body mass index category as normal (28.8%), overweight (50%), obese (16.4%) and very obese (4.8%). Mean followup was 51.3 ± 38.5 months. During followup there were 1,044 deaths with 220 (21.1%) from prostate cancer. Stratified by body mass index category the groups differed with regard to the need for secondary treatment (p = 0.05) and overall mortality (p <0.01) but there were no significant differences with regard to disease specific survival (p = 0.09). On multivariate analysis age 65 to 74 years (HR 2.4, p = 0.002), age older than 75 years (HR 3.2, p = 0.0001), high risk disease (HR 1.6, p <0.0001), conservative treatment (HR 1.2, p <0.0001) and presence of diabetes (HR 1.6, p <0.0001) were associated with decreased overall survival. Only conservative treatment (HR 1.4, p <0.0001), high risk disease (HR 8.4, p <0.0001) and intermediate risk disease (HR 2.5, p = 0.004) were associated with decreased disease specific survival. Conclusions: In a prospective, community based cohort we were unable to establish a relationship between body mass index and prostate cancer disease specific survival or overall survival.

KW - body mass index

KW - mortality

KW - obesity

KW - prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=67349106243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349106243&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.02.118

DO - 10.1016/j.juro.2009.02.118

M3 - Article

C2 - 19447437

AN - SCOPUS:67349106243

VL - 182

SP - 112

EP - 117

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -